Silicon Motion Technology (SIMO) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket
 


Silicon Motion Technology Corporation  (NASDAQ: SIMO)
    Sector • Technology    Industry • Semiconductors
   Industry • Semiconductors
   Sector • Technology

Silicon Motion Technology's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Silicon Motion Technology in the fourth quarter 2025?
Silicon Motion Technology Corporation achieved a return on average equity (ROE) of 14.76 % in its fourth quarter 2025, which is below Silicon Motion Technology's average return on equity, which stands at 16.62%.

ROE has advanced compared to 10.94% in the third quarter 2025, due to net income growth.

Within the Semiconductors industry 23 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 949, from total ROE ranking in the third quarter 2025 at 1169.

What is ROE?




Return On Equity (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Equity Change 7.57 % 7.57 % 7.57 % 7.57 % -
Y / Y Net Income Change 37.41 % - - - 68.8 %
Net Income (TTM) in Millions 123 89 89 89 89
Return On Equity (TTM) 14.76 % 10.94 % 11.14 % 11.34 % 11.56 %
SIMO's Total Ranking # 949 # 1169 # # #
Equity (TTM) in Millions 831 831 831 831 772
Seq. Equity Change 0 % 0 % 0 % 7.57 % 0 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 24
Sector # 168
Overall # 949

Return On Equity Statistics
High Average Low
30.41 %
16.62 %
7.2 %
(Dec 31 2021)   (Dec 31 2023)



  News about Silicon Motion Technology Corporation Return on Equity ROE

Novotech Fortifies Drug Development Consulting Team with Scott Schliebner Appointment; Silicon Motion Technology Corporation Witnesses Impressive Stock Surge

Novotech Appoints Scott Schliebner as Vice President and Global Head, Drug Development Consulting
Novotech CRO, a leading contract research organization in the field of drug development, has announced the appointment of Scott Schliebner as Vice President and Global Head of Drug Development Consulting. With his extensive experience in commercial and clinical life sciences, Schliebner is expected to bring valuable expertise to Novotech s team.
Schliebner s appointment comes at a crucial time for Novotech as the company aims to enhance its drug development consulting services globally. With the increasing complexity and rigorous regulatory requirements in the pharmaceutical industry, Novotech recognized the need for a seasoned specialist to lead its consulting team.

Silicon Motion's CFO Transition and ROE Analysis Pave the Way for a New Chapter


In a recent announcement, Silicon Motion Technology Corporation revealed a significant change in its executive team. Jason Tsai, currently serving as the VP of IR and Finance at Silicon Motion, has been appointed as the Interim Chief Financial Officer of the Company. This transition follows the stepping down of Mr. Riyadh Lai as the Chief Financial Officer.
This move marks a shift in leadership within Silicon Motion, as Jason Tsai takes over the top financial position. Tsai s experience in investor relations and finance suggests that he brings valuable insights to the role. However, questions may arise regarding the motivation behind this change, as details regarding Lai s departure remain undisclosed.




SIMO Annual Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Equity in Millions 831 772 735 733 658
Y / Y Equity Change 7.57 % 5.12 % 0.29 % 11.4 % 17.91 %
Net Income in Millions 123 89 53 173 200
Y / Y Net Income Change 37.41 % 68.8 % -69.35 % -13.75 % 150.8 %
Return On Equity 14.76 % 11.56 % 7.2 % 23.55 % 30.41 %





Annual Roe Comment
In 2025 ROE improved to 14.76 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Semiconductors Industry Roe Trends and Statistics
Technology Sector Return On Equity Statistics
SIMO's' Return on Equity at Yahoo Finance
SIMO's Roe Ratio versus Semiconductors Industry, Technology Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SIMO's Competitors
Subscribers only: Roe for Silicon Motion Technology's Suppliers
Subscribers only: Return On Equity for SIMO's Customers




Companies with similar Return On Equity at Dec 31 2025, within Technology Sector ROE
Vertiv Holdings Co  40.26 %
Lumentum Holdings Inc   39.95 %
Autodesk Inc   39.89 %
Credo Technology Group Holding Ltd  39.62 %
Applied Materials Inc  39.54 %
Cargurus Inc   39.29 %
Marvell Technology Inc  38.73 %
Qualys Inc   37.83 %
Formula Systems 1985 Ltd  37.63 %
International Business Machines Corporation  36.76 %
Check Point Software Technologies Ltd   36.67 %
Duolingo Inc   36.60 %
Life360 Inc   35.86 %
Amphenol Corporation  35.84 %
Innodata inc   35.14 %
Alphabet Inc   35.00 %
Bk Technologies Corp  34.98 %
Microsoft Corporation  34.77 %
Veralto Corporation  34.42 %
Logitech International s a   33.40 %
Fiee Inc   33.19 %
Ibex Limited  33.05 %
Broadcom Inc   32.70 %
Joyy inc  31.91 %
Innovative Solutions And Support inc   31.65 %
Taiwan Semiconductor Manufacturing Company Limited  31.41 %
Arista Networks inc   31.01 %
Leidos Holdings Inc   30.90 %
Sohu com Limited  30.84 %
Meta Platforms Inc   30.56 %


Date modified: 2026-09-08T15:11:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.